Search Within

CTCR Scholars

Formats
  1. Meeting Abstract (877)
  2. Journal Article (576)
  3. Review (73)
  4. Research Letter (39)
  5. Editorial (30)
  6. Correspondence (25)
  7. Miscellaneous (19)
  8. Book Section (11)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. Department of Medicine (1431)
  2. Hematologic Malignancies, Division of (1088)
  3. MSK Grad Students (1031)
  4. Master of Science in Clinical and Translational Cancer Research (996)
  5. Center for Hematologic Malignancies (990)
  6. Survivorship Research (931)

More Groups

People
  1. Sergio Giralt (557)
  2. Miguel-Angel Perales (413)
  3. Michael Scordo (389)
  4. Gunjan Shah (345)
  5. Sean Devlin (334)
  6. Parastoo Dahi (305)

More People

Years
  1. 2025 (117)
  2. 2024 (254)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (318)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (144)
  4. Annals of Surgical Oncology (87)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (56)

More Publications

Publishers
  1. American Society of Hematology (373)
  2. Elsevier Inc. (343)
  3. American Society of Clinical Oncology (160)
  4. Nature Publishing Group (137)
  5. Springer (107)
  6. American Association for Cancer Research (67)

More Publishers

Results (1661)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CD5-positive marginal zone lymphoma: Clinical characteristics of the MSKCC Cohort, and comparison with the CD5-negative population
    Meeting Abstract

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Lia Palomba, M.; Noy, A.; Matasar, M. J.; Caron, P.; Hamilton, A.; Hamlin, P. A.; Kumar, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Initial whole genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Meeting Abstract

    Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; Iacobuzio-Donahue, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and COVID-19 severity in cancer patients
    Meeting Abstract

    Bolton, K. L.; Foote, M.; Jee, J.; Safonov, A.; Ptashkin, R.; Devlin, S.; Gedvilaite, E.; Gao, T.; Papaemmanuil, E.; Pessin, M. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in Claudin 18.2-positive metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Park, W.; O'Reilly, E. M.; Furuse, J.; Kunieda, F.; Jie, F.; Kindler, H. L.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab
    Meeting Abstract

    Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genetic algorithms to identify homologous recombination deficiency (HRD) in pancreas adenocarcinoma
    Meeting Abstract

    Park, W.; Chen, J.; Chou, J. F.; Iacobuzio-Donague, C.; Riaz, N.; O'Reilly, E. M.
    Cancer Research (2020)

    Fulltext@MSK | Save